These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 31199104)

  • 1. Dorsolateral prefrontal γ-aminobutyric acid in patients with treatment-resistant depression after transcranial magnetic stimulation measured with magnetic resonance spectroscopy.
    Levitt JG; Kalender G; O’Neill J; Diaz JP; Cook IA; Ginder N; Krantz D; Minzenberg MJ; Vince-Cruz N; Nguyen LD; Alger JR; Leuchter AF
    J Psychiatry Neurosci; 2019 Nov; 44(6):386-394. PubMed ID: 31199104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated prefrontal cortex GABA in patients with major depressive disorder after TMS treatment measured with proton magnetic resonance spectroscopy.
    Dubin MJ; Mao X; Banerjee S; Goodman Z; Lapidus KA; Kang G; Liston C; Shungu DC
    J Psychiatry Neurosci; 2016 Apr; 41(3):E37-45. PubMed ID: 26900793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repetitive Transcranial Magnetic Stimulation-Associated Changes in Neocortical Metabolites in Major Depression: A Systematic Review.
    Gonsalves MA; White TL; Barredo J; Fukuda AM; Joyce HE; Harris AD; Carpenter LL
    Neuroimage Clin; 2022; 35():103049. PubMed ID: 35738081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of rTMS on GABA and glutamate levels in treatment-resistant depression: An MR spectroscopy study.
    Godfrey KEM; Muthukumaraswamy SD; Stinear CM; Hoeh N
    Psychiatry Res Neuroimaging; 2021 Nov; 317():111377. PubMed ID: 34479176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Health-related quality of life assessment in depression after low-frequency transcranial magnetic stimulation].
    Dumas R; Boyer L; Richieri R; Guedj E; Auquier P; Lançon C
    Encephale; 2014 Feb; 40(1):74-80. PubMed ID: 24091070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alteration of gamma-aminobutyric acid in the left dorsolateral prefrontal cortex of individuals with chronic insomnia: a combined transcranial magnetic stimulation-magnetic resonance spectroscopy study.
    Zhang H; Huang X; Wang C; Liang K
    Sleep Med; 2022 Apr; 92():34-40. PubMed ID: 35325767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in dorsolateral prefrontal connectivity after rTMS in treatment-resistant depression: a brain perfusion SPECT study.
    Richieri R; Jouvenoz D; Verger A; Fiat P; Boyer L; Lançon C; Guedj E
    Eur J Nucl Med Mol Imaging; 2017 Jun; 44(6):1051-1055. PubMed ID: 28154905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Impact of Accelerated HF-rTMS on the Subgenual Anterior Cingulate Cortex in Refractory Unipolar Major Depression: Insights From 18FDG PET Brain Imaging.
    Baeken C; Marinazzo D; Everaert H; Wu GR; Van Hove C; Audenaert K; Goethals I; De Vos F; Peremans K; De Raedt R
    Brain Stimul; 2015; 8(4):808-15. PubMed ID: 25744500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness and acceptability of accelerated repetitive transcranial magnetic stimulation (rTMS) for treatment-resistant major depressive disorder: an open label trial.
    McGirr A; Van den Eynde F; Tovar-Perdomo S; Fleck MP; Berlim MT
    J Affect Disord; 2015 Mar; 173():216-20. PubMed ID: 25462419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of prefrontal target region on the efficacy of repetitive transcranial magnetic stimulation in patients with medication-resistant depression: a [(18)F]-fluorodeoxyglucose PET and MRI study.
    Paillère Martinot ML; Galinowski A; Ringuenet D; Gallarda T; Lefaucheur JP; Bellivier F; Picq C; Bruguière P; Mangin JF; Rivière D; Willer JC; Falissard B; Leboyer M; Olié JP; Artiges E; Martinot JL
    Int J Neuropsychopharmacol; 2010 Feb; 13(1):45-59. PubMed ID: 19267956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted transcranial theta-burst stimulation alters fronto-insular network and prefrontal GABA.
    Iwabuchi SJ; Raschke F; Auer DP; Liddle PF; Lankappa ST; Palaniyappan L
    Neuroimage; 2017 Feb; 146():395-403. PubMed ID: 27651067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prefrontal cortical blood flow predicts response of depression to rTMS.
    Weiduschat N; Dubin MJ
    J Affect Disord; 2013 Sep; 150(2):699-702. PubMed ID: 23707032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The alteration of retinal nerve fibre layer thickness with repetitive transcranial magnetic stimulation in patients with treatment resistant major depression.
    Genc A; Dalkıran M; Pirdoğan Aydın E; Türkyılmaz Uyar E; Alkan A; Guven D; Özer ÖA; Karamustafalıoğlu O
    Int J Psychiatry Clin Pract; 2019 Mar; 23(1):57-61. PubMed ID: 30596524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive safety of dorsomedial prefrontal repetitive transcranial magnetic stimulation in major depression.
    Schulze L; Wheeler S; McAndrews MP; Solomon CJ; Giacobbe P; Downar J
    Eur Neuropsychopharmacol; 2016 Jul; 26(7):1213-26. PubMed ID: 27157074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glutamate alterations associated with transcranial magnetic stimulation in youth depression: a case series.
    Yang XR; Kirton A; Wilkes TC; Pradhan S; Liu I; Jaworska N; Damji O; Keess J; Langevin LM; Rajapakse T; Lebel RM; Sembo M; Fife M; MacMaster FP
    J ECT; 2014 Sep; 30(3):242-7. PubMed ID: 24820947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive value of dorso-lateral prefrontal connectivity for rTMS response in treatment-resistant depression: A brain perfusion SPECT study.
    Richieri R; Verger A; Boyer L; Boucekine M; David A; Lançon C; Cermolacce M; Guedj E
    Brain Stimul; 2018; 11(5):1093-1097. PubMed ID: 29802071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in brain connectivity during a sham-controlled, transcranial magnetic stimulation trial for depression.
    Taylor SF; Ho SS; Abagis T; Angstadt M; Maixner DF; Welsh RC; Hernandez-Garcia L
    J Affect Disord; 2018 May; 232():143-151. PubMed ID: 29494898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of motor cortex excitability predicts antidepressant response to prefrontal cortex repetitive transcranial magnetic stimulation.
    Oliveira-Maia AJ; Press D; Pascual-Leone A
    Brain Stimul; 2017; 10(4):787-794. PubMed ID: 28438543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dorsomedial prefrontal cortex repetitive transcranial magnetic stimulation for treatment-refractory major depressive disorder: A three-arm, blinded, randomized controlled trial.
    Dunlop K; Sheen J; Schulze L; Fettes P; Mansouri F; Feffer K; Blumberger DM; Daskalakis ZJ; Kennedy SH; Giacobbe P; Woodside B; Downar J
    Brain Stimul; 2020; 13(2):337-340. PubMed ID: 31711880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional connectivity of the anterior cingulate cortex predicts treatment outcome for rTMS in treatment-resistant depression at 3-month follow-up.
    Ge R; Downar J; Blumberger DM; Daskalakis ZJ; Vila-Rodriguez F
    Brain Stimul; 2020; 13(1):206-214. PubMed ID: 31668646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.